Erin Sue Crow, RN, PMHNP-BC

2.5 times the Medicare Part D claims of the average psychiatric/mental health nurse practitioner in 2024

2,223 Medicare Part D claims for 133 beneficiaries, against an average of 906 among the 30,717 providers of this specialty who prescribed in Part D. Brand-name drugs were 13% of claims.

Most prescribed

1. Clozapine171 claims
2. Hydroxyzine Pamoate117 claims
3. Trazodone Hcl117 claims
4. Invega Sustenna108 claims
5. Mirtazapine108 claims
6. Buspirone Hcl95 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 85.3 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $217.67

2 payments; by number, the most common kind was food and beverage; the largest payer was Teva Pharmaceuticals USA, Inc. The 23,362 providers of this specialty with any payment received $1,027.77 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.